Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jeffrey Jones

Showing results (111-120 of 151) with videos related to

Pageof 16
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2020
Early Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic LeukemiaShanmugapriya Thangavadivel, Qiuhong Zhao, Narendranath Epperla, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2015
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemiaJames S Blachly, Amy S Ruppert, Weiqiang Zhao, et al.
The Journal of Orthopaedic and Sports Physical Therapy|October 4, 2016
MicroRNA 320a Predicts Chronic Axial and Widespread Pain Development Following Motor Vehicle Collision in a Stress-Dependent MannerSarah D Linnstaedt, Kyle D Riker, Margaret G Walker, et al.
Blood|December 2, 2017
Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignanciesIan W Flinn, Susan O'Brien, Brad Kahl, et al.
Leukemia Research|August 2, 2014
A dose escalation feasibility study of lenalidomide for treatment of symptomatic, relapsed chronic lymphocytic leukemiaKami Maddocks, Amy S Ruppert, Rebekah Browning, et al.
Frontiers in Social Psychology|November 7, 2025
Quantifying generalized trust in individuals and counties using languageSalvatore Giorgi, Jason Jeffrey Jones, Anneke Buffone, et al.
The Journal of Urology|December 6, 2017
Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter StudySiamak Daneshmand, Sanjay Patel, Yair Lotan, et al.
Molecular Pharmacology|March 24, 2011
RNA-induced silencing complex-bound small interfering RNA is a determinant of RNA interference-mediated gene silencing in miceJie Wei, Jeffrey Jones, Jing Kang, et al.
American Journal of Hematology|August 11, 2018
Duvelisib, an oral dual PI3K-δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 studySusan O'Brien, Manish Patel, Brad S Kahl, et al.
Leukemia Research|July 23, 2013
Cyclophosphamide, alvocidib (flavopiridol), and rituximab, a novel feasible chemoimmunotherapy regimen for patients with high-risk chronic lymphocytic leukemiaDeborah M Stephens, Amy S Ruppert, Kami Maddocks, et al.
Pageof 16

Showing results (111-120 of 151) with videos related to

Sort By:
Pageof 16
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 22, 2020
Early Intervention with Lenalidomide in Patients with High-risk Chronic Lymphocytic LeukemiaShanmugapriya Thangavadivel, Qiuhong Zhao, Narendranath Epperla, et al.
Proceedings of the National Academy of Sciences of the United States of America|March 20, 2015
Immunoglobulin transcript sequence and somatic hypermutation computation from unselected RNA-seq reads in chronic lymphocytic leukemiaJames S Blachly, Amy S Ruppert, Weiqiang Zhao, et al.
The Journal of Orthopaedic and Sports Physical Therapy|October 4, 2016
MicroRNA 320a Predicts Chronic Axial and Widespread Pain Development Following Motor Vehicle Collision in a Stress-Dependent MannerSarah D Linnstaedt, Kyle D Riker, Margaret G Walker, et al.
Blood|December 2, 2017
Duvelisib, a novel oral dual inhibitor of PI3K-δ,γ, is clinically active in advanced hematologic malignanciesIan W Flinn, Susan O'Brien, Brad Kahl, et al.
Leukemia Research|August 2, 2014
A dose escalation feasibility study of lenalidomide for treatment of symptomatic, relapsed chronic lymphocytic leukemiaKami Maddocks, Amy S Ruppert, Rebekah Browning, et al.
Frontiers in Social Psychology|November 7, 2025
Quantifying generalized trust in individuals and counties using languageSalvatore Giorgi, Jason Jeffrey Jones, Anneke Buffone, et al.
The Journal of Urology|December 6, 2017
Efficacy and Safety of Blue Light Flexible Cystoscopy with Hexaminolevulinate in the Surveillance of Bladder Cancer: A Phase III, Comparative, Multicenter StudySiamak Daneshmand, Sanjay Patel, Yair Lotan, et al.
Molecular Pharmacology|March 24, 2011
RNA-induced silencing complex-bound small interfering RNA is a determinant of RNA interference-mediated gene silencing in miceJie Wei, Jeffrey Jones, Jing Kang, et al.
American Journal of Hematology|August 11, 2018
Duvelisib, an oral dual PI3K-δ,γ inhibitor, shows clinical and pharmacodynamic activity in chronic lymphocytic leukemia and small lymphocytic lymphoma in a phase 1 studySusan O'Brien, Manish Patel, Brad S Kahl, et al.
Leukemia Research|July 23, 2013
Cyclophosphamide, alvocidib (flavopiridol), and rituximab, a novel feasible chemoimmunotherapy regimen for patients with high-risk chronic lymphocytic leukemiaDeborah M Stephens, Amy S Ruppert, Kami Maddocks, et al.
Pageof 16